Shiloh
Editor, Senior Moderator
Source: http://www.gantdaily.com/news/71/ARTICLE/60066/2009-08-28.html
August 28th, 2009
Ottawa Boosts Training Of Healthcare Workers In Dealing With Influenza A (H1N1) Cases
AHN Staff
Ottawa, Ontario (AHN) - Health Minister Leona Aglukkaq said the federal government is boosting the training of Canada's healthcare workers in treating Influenza A (H1N1) virus cases. It will be through two initiatives Ottawa launched Thursday.
The first is a meeting in Winnipeg on Sept. 2 and 3 of public health officials, intensive care experts and medical specialists from Canada and overseas in which they would share and tackle best practices for handling severe swine flu cases. It would be organized by the Public Health Agency of Canada.
The second is the allocation of an extra $2.7 billion to the Influenza Research Network to evaluate the safety and effectiveness of the H1N1 vaccine being developed and to track and study the vaccine implementation programs. The funds will come from the PHAC and the Canadian Institute for Health Research.
The further probe on the safety of the swine flu shots came after a study showed that some sectors like healthcare workers and parents are hesitant to have shots for fear that the vaccines have not been thoroughly tested and they would just be guinea pigs for the shots.
Chief Public Health Officer Dr. David Butler-Jones said in a statement, "Coming out of this meeting, we aim to have new guidelines on treatment and management of severe cases, as well as some guidance on issues like identifying surge capacity for hospitals during a more severe outbreak."
CIHR Institute of Infection and Immunity Scientific Director Dr. Bhagirath Singh said the network - which will be headed by Dr. Scott Halperin - will strengthen Canada's capacity to track effectively and evaluate the H1N1 vaccine and its delivery. Halperin is the Canadian Center for Vaccinology director in Halifax. Eighty scientists from 30 research and public health institutions across Canada will man the network.
Butler-Jones said he expects GlaxoSmithKline, from whom Ottawa ordered 50 million doses of the H1N1 vaccine, to be ready with the shots by middle of November. However, health officials are also studying if they could hasten the production and delivery time.
August 28th, 2009
Ottawa Boosts Training Of Healthcare Workers In Dealing With Influenza A (H1N1) Cases
AHN Staff
Ottawa, Ontario (AHN) - Health Minister Leona Aglukkaq said the federal government is boosting the training of Canada's healthcare workers in treating Influenza A (H1N1) virus cases. It will be through two initiatives Ottawa launched Thursday.
The first is a meeting in Winnipeg on Sept. 2 and 3 of public health officials, intensive care experts and medical specialists from Canada and overseas in which they would share and tackle best practices for handling severe swine flu cases. It would be organized by the Public Health Agency of Canada.
The second is the allocation of an extra $2.7 billion to the Influenza Research Network to evaluate the safety and effectiveness of the H1N1 vaccine being developed and to track and study the vaccine implementation programs. The funds will come from the PHAC and the Canadian Institute for Health Research.
The further probe on the safety of the swine flu shots came after a study showed that some sectors like healthcare workers and parents are hesitant to have shots for fear that the vaccines have not been thoroughly tested and they would just be guinea pigs for the shots.
Chief Public Health Officer Dr. David Butler-Jones said in a statement, "Coming out of this meeting, we aim to have new guidelines on treatment and management of severe cases, as well as some guidance on issues like identifying surge capacity for hospitals during a more severe outbreak."
CIHR Institute of Infection and Immunity Scientific Director Dr. Bhagirath Singh said the network - which will be headed by Dr. Scott Halperin - will strengthen Canada's capacity to track effectively and evaluate the H1N1 vaccine and its delivery. Halperin is the Canadian Center for Vaccinology director in Halifax. Eighty scientists from 30 research and public health institutions across Canada will man the network.
Butler-Jones said he expects GlaxoSmithKline, from whom Ottawa ordered 50 million doses of the H1N1 vaccine, to be ready with the shots by middle of November. However, health officials are also studying if they could hasten the production and delivery time.